Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (191-200 of 357) with videos related to

Pageof 36
Sort By:
British Journal of Cancer|November 1, 1990
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survivalA R Dixon, J F Robertson, L Jackson, et al.
International Journal of Cancer|June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145H E Jones, C M Dutkowski, D Barrow, et al.
Breast Cancer Research and Treatment|January 1, 1994
Biological factors of prognostic significance in locally advanced breast cancerJ F Robertson, I O Ellis, D Pearson, et al.
Breast Cancer Research : BCR|December 6, 2008
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cellsAnnabel C Borley, Stephen Hiscox, Julia Gee, et al.
British Journal of Cancer|September 1, 1981
Oestrogen-receptor status and sites of metastasis in breast cancerF C Campbell, R W Blamey, C W Elston, et al.
The British Journal of Surgery|June 1, 1988
Effect of LHRH agonist, Zoladex, on ovarian histologyK Williamson, J F Robertson, I O Ellis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992
Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancerN P Sacks, J F Robertson, I O Ellis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2006
Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cellsFrancesca Greco, María J Vicent, Siobhan Gee, et al.
Journal of Animal Science|April 1, 1993
Shipping stress and social status effects on pig performance, plasma cortisol, natural killer cell activity, and leukocyte numbersJ J McGlone, J L Salak, E A Lumpkin, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancerR I Nicholson, J M Gee, D L Manning, et al.
Pageof 36

Showing results (191-200 of 357) with videos related to

Sort By:
Pageof 36
British Journal of Cancer|November 1, 1990
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survivalA R Dixon, J F Robertson, L Jackson, et al.
International Journal of Cancer|June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145H E Jones, C M Dutkowski, D Barrow, et al.
Breast Cancer Research and Treatment|January 1, 1994
Biological factors of prognostic significance in locally advanced breast cancerJ F Robertson, I O Ellis, D Pearson, et al.
Breast Cancer Research : BCR|December 6, 2008
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cellsAnnabel C Borley, Stephen Hiscox, Julia Gee, et al.
British Journal of Cancer|September 1, 1981
Oestrogen-receptor status and sites of metastasis in breast cancerF C Campbell, R W Blamey, C W Elston, et al.
The British Journal of Surgery|June 1, 1988
Effect of LHRH agonist, Zoladex, on ovarian histologyK Williamson, J F Robertson, I O Ellis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992
Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancerN P Sacks, J F Robertson, I O Ellis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2006
Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cellsFrancesca Greco, María J Vicent, Siobhan Gee, et al.
Journal of Animal Science|April 1, 1993
Shipping stress and social status effects on pig performance, plasma cortisol, natural killer cell activity, and leukocyte numbersJ J McGlone, J L Salak, E A Lumpkin, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancerR I Nicholson, J M Gee, D L Manning, et al.
Pageof 36